These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17205454)

  • 1. The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients.
    McGovern BH; Golan Y; Lopez M; Pratt D; Lawton A; Moore G; Epstein M; Knox TA
    Clin Infect Dis; 2007 Feb; 44(3):431-7. PubMed ID: 17205454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cirrhosis is associated with low CD4+ T cell counts: implications for HIV-infected patients with liver disease.
    Gandhi RT
    Clin Infect Dis; 2007 Feb; 44(3):438-40. PubMed ID: 17205455
    [No Abstract]   [Full Text] [Related]  

  • 3. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
    Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
    J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus.
    Hull MW; Rollet K; Odueyungbo A; Saeed S; Potter M; Cox J; Cooper C; Gill J; Klein MB;
    Clin Infect Dis; 2012 Jun; 54(12):1798-805. PubMed ID: 22460964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, China.
    Xu JQ; Wang JJ; Han LF; Xu C; Ruan YH; Xu ZH; Chen X; Liu ZD; Wang J; Su B; Ding XP; Gao B; Gu YB; Cao XY; Xing H; Hong KX; Peng H; Zhao QB; Yuan L; Feng Y; Zhang GY; Ma LY; Wu L; Shao YM
    Chin Med J (Engl); 2006 Dec; 119(23):1941-8. PubMed ID: 17199937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?
    Bongiovanni M; Gori A; Lepri AC; Antinori A; de Luca A; Pagano G; Chiodera A; Puoti M; Monforte Ad;
    Clin Infect Dis; 2007 Sep; 45(5):650-3. PubMed ID: 17683003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing CD4+ T-cell count during suppressed or low-level viraemia in patients with HIV infection.
    Anderson AM; Kosinski AS; Bartlett JA
    Antivir Ther; 2007; 12(7):1041-8. PubMed ID: 18018762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low CD4 T cell counts before HIV-1 seroconversion do not affect disease progression in Ethiopian factory workers.
    Mekonnen Y; Geskus RB; Hendriks JC; Messele T; Borghans J; Miedema F; Wolday D; Coutinho RA; Dukers NH
    J Infect Dis; 2005 Sep; 192(5):739-48. PubMed ID: 16088823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
    Matthews GV; Cooper DA; Dore GJ
    Antivir Ther; 2007; 12(1):119-22. PubMed ID: 17503756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts.
    Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI
    Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic CD4+ T-lymphocytopenia--an analysis of five patients with unexplained opportunistic infections.
    Spira TJ; Jones BM; Nicholson JK; Lal RB; Rowe T; Mawle AC; Lauter CB; Shulman JA; Monson RA
    N Engl J Med; 1993 Feb; 328(6):386-92. PubMed ID: 8093635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
    J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl.
    Mouala C; Guiguet M; Houzé S; Damond F; Pialoux G; Viget N; Costagliola D; Le Bras J; Matheron S;
    AIDS; 2009 Sep; 23(15):1997-2004. PubMed ID: 19654499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
    Matsui T; Nagai H; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):401-6. PubMed ID: 17932673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
    Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
    Castellares C; Barreiro P; Martín-Carbonero L; Labarga P; Vispo ME; Casado R; Galindo L; García-Gascó P; García-Samaniego J; Soriano V
    J Viral Hepat; 2008 Mar; 15(3):165-72. PubMed ID: 18233989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentration of acute phase protein and lipid profile in HIV-1 seropositive patients and its relationship to the progression of the disease.
    Ogunro PS; Idogun ES; Ogungbamigbe TO; Ajala MO; Olowu OA
    Niger Postgrad Med J; 2008 Dec; 15(4):219-24. PubMed ID: 19169337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.